Search research articles
Contact Us
Filters
Showing results (21-30 of 104) with videos related to
Page
of 11
Sort By:
Annals of Internal Medicine
|
April 1, 1979
Fine structure of the Legionnaires' disease bacterium. In-vitro and in-vivo studies of four isolates
J A Keel, W R Finnerty, J C Feeley
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale
|
January 1, 1984
Overview of neonatal listeriosis
W L Albritton, S L Cochi, J C Feeley
Journal of Clinical Microbiology
|
November 1, 1979
Upper limit of normal titer for detection of antibodies to Legionella pneumophila by the microagglutination test
G C Klein, W L Jones, J C Feeley
Diagnostic Immunology
|
January 1, 1983
Use of cholera toxoid in an enzyme-linked immunosorbent assay for antitoxin
D D Cruce, I K Wachsmuth, J C Feeley
Annals of Internal Medicine
|
April 1, 1979
Cellular lipids of the Legionnaires' disease bacterium
W R Finnerty, R A Makula, J C Feeley
Antimicrobial Agents and Chemotherapy
|
April 1, 1972
In vitro susceptibility of El Tor and classical Vibrio cholerae strains to trimethoprim and sulfamethoxazole
R S Northrup, M A Doyle, J C Feeley
Annals of Internal Medicine
|
April 1, 1979
Immunologic factors affecting the in-vivo and in-vitro survival of the Legionnaires' disease bacterium
R J Arko, K H Wong, J C Feeley
Infection and Immunity
|
November 1, 1984
Presence of toxic shock toxin in toxic shock and other clinical strains of Staphylococcus aureus
M W Reeves, L Pine, J C Feeley, et al.
The American Journal of Emergency Medicine
|
November 1, 1989
Tetanus immunity in emergency department patients
T O Stair, M A Lippe, H Russell, et al.
The Yale Journal of Biology and Medicine
|
July 1, 1984
Susceptibility of the Lyme disease spirochete to seven antimicrobial agents
S E Johnson, G C Klein, G P Schmid, et al.
Page
of 11
Search research articles
Search
Showing results (21-30 of 104) with videos related to
Sort By:
Page
of 11
Annals of Internal Medicine
|
April 1, 1979
Fine structure of the Legionnaires' disease bacterium. In-vitro and in-vivo studies of four isolates
J A Keel, W R Finnerty, J C Feeley
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale
|
January 1, 1984
Overview of neonatal listeriosis
W L Albritton, S L Cochi, J C Feeley
Journal of Clinical Microbiology
|
November 1, 1979
Upper limit of normal titer for detection of antibodies to Legionella pneumophila by the microagglutination test
G C Klein, W L Jones, J C Feeley
Diagnostic Immunology
|
January 1, 1983
Use of cholera toxoid in an enzyme-linked immunosorbent assay for antitoxin
D D Cruce, I K Wachsmuth, J C Feeley
Annals of Internal Medicine
|
April 1, 1979
Cellular lipids of the Legionnaires' disease bacterium
W R Finnerty, R A Makula, J C Feeley
Antimicrobial Agents and Chemotherapy
|
April 1, 1972
In vitro susceptibility of El Tor and classical Vibrio cholerae strains to trimethoprim and sulfamethoxazole
R S Northrup, M A Doyle, J C Feeley
Annals of Internal Medicine
|
April 1, 1979
Immunologic factors affecting the in-vivo and in-vitro survival of the Legionnaires' disease bacterium
R J Arko, K H Wong, J C Feeley
Infection and Immunity
|
November 1, 1984
Presence of toxic shock toxin in toxic shock and other clinical strains of Staphylococcus aureus
M W Reeves, L Pine, J C Feeley, et al.
The American Journal of Emergency Medicine
|
November 1, 1989
Tetanus immunity in emergency department patients
T O Stair, M A Lippe, H Russell, et al.
The Yale Journal of Biology and Medicine
|
July 1, 1984
Susceptibility of the Lyme disease spirochete to seven antimicrobial agents
S E Johnson, G C Klein, G P Schmid, et al.
Page
of 11